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completed SF-12 at preinjection and 6 months and an expectations
questionnaire prior to surgery. 20 patient expectation domains were
measured and analyzed individually, as “very important” to “of little to
no importance”.
17 patients dropped out due to non-medical reasons. Of 46 remaining, 27
were female, 18 male. Average age was 65 (range 42−81). 30 patients
(65%) reported previous knee surgery.
Results: All patients reported pain as reason for seeking medical treat-
ment. Pain relief was very important to only 66% of patients and some-
what important to 12%. If patients expected pain relief, 43% expected
most pain to be relieved. 36% expected all pain to be relieved. 17 (37%)
reported stiffness as primary reason for seeking medical treatment. Only
54% of patients expected knee stiffness/swelling to stop. Improving ability
to walk was considered very important in 89% and they expected to walk
more than 1 mile. 80% of patients considered return to recreational sports
an important expectation and somewhat important in 13%. The most
important expectation in this group was to have conﬁdence in their knee,
avoid future knee degeneration and improve ability to maintain general
health. All patients rated these important. Getting knee back to where it
was before problem started was only important in 66% of patients.
No patient discontinued injection series due to negative response to
injection. 3 (7%) required surgery prior to 6 month time-point. All 3 had
previous knee surgery. Average age of failures was 68 (range 66−70).
In the 43 patients, results showed positive response in initial weeks
following completion of injection series (Figure). Patients at 6 months
showed signiﬁcant improvement in pain, WOMAC score, Lysholm and
SF-12 physical component.
Pre-injection 6 months p-value
Lysholm 40 62 0.001
WOMAC Pain 7 5 0.004
WOMAC Total 28 23 0.047
SF-12 PCS 41 45 0.015
SF-12 MCS 57 58 0.795
Conclusions: In these patients, regaining function was the most im-
portant expectation for injection treatment. Improving ability to walk and
returning to recreational activity showed to be more important to patients
than reducing symptoms. Although patients had higher expectations for
improvement in knee function, Hylan G-F 20 with corticosteroid, showed
to signiﬁcantly improve function, and signiﬁcantly decrease pain. Hylan
G-F 20 and corticosteroid may be a good treatment option for older
patients suffering from osteoarthritis, who desire to return to an active
lifestyle.
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Purpose: The potential for intra-articular treatments to improve the med-
ical management of osteoarthritis (OA) continues to receive increasing
attention, particularly for patients in whom one or two problem joints drive
their disability. To improve the procedure for administering intra-articular
therapies, a new syringe-like device was speciﬁcally designed for mus-
culoskeletal aspiration/injection procedures. Termed the Reciprocating
Procedure Device (RPD), this device enables signiﬁcantly more precise
control of needle position, reduces procedure pain and trauma, increases
the volume of synovial ﬂuid that can be collected, and decreases the
time for performing intra-articular procedures (Arthritis & Rheumatism, in
press). These attributes are important for both therapy and biomarker
analysis. Corticosteroid and hyaluronan are the agents most commonly
administered by intra-articular injection, both of which require precise
delivery of the agent to the anatomical intra-articular space. In this trial
we hypothesized that the outcome of local therapy for OA was dependent
on the needle placement and needle control characteristics of the device
used for arthrocentesis and injection.
Methods: One hundred patients with symptomatic OA in a single large
joint were enrolled in an IRB-approved protocol, registered at clinical-
trials.gov. Patients were randomized to have arthrocentesis and intra-
articular corticosteroid injection performed using either the RPD or a
conventional syringe. The primary outcome measure was pain in the
affected joint, measured (1) at baseline (prior to the procedure), (2) during
local anesthesia, (3) during the arthrocentesis/injection procedure itself,
(4) at 2 weeks post-procedure, and (5) at 6 months post-procedure. Pain
was measured using a Visual Analogue Pain Scale (VAPS) (0 = no pain,
10 =most severe pain) with signiﬁcant pain being deﬁned as a VAPS
score >5.
Results: The group randomized to the RPD experienced signiﬁcantly
reduced pain scores during both local anesthesia administration (Syringe:
6.75±2.51; RPD: 3.63±1.98, p< 0.001), and during the arthrocente-
sis/injection procedure (Syringe: 4.25±2.51; RPD 2.54±1.98, p< 0.001).
With respect to longer term treatment outcomes, the RPD was signif-
icantly more effective than the conventional syringe in reducing pain
scores at 2 weeks (Syringe: 3.27±3.41; RPD: 1.89±0.98, p< 0.001),
the time point at which corticosteroid injections are expected to exhibit
their greatest efﬁcacy. Pain scores at 6 months trended toward improved
effectiveness for the RPD group (Syringe: 6.67±2.41; RPD: 4.89±2.98,
p = 0.06).
Conclusions: Though both groups experience the therapeutic beneﬁt
expected from intra-articular corticosteroid injection, this study demon-
strates that the device used to administer intra-articular therapy can inﬂu-
ence the safety and effectiveness of the procedure itself. Moreover, the
data demonstrate that the RPD signiﬁcantly improves patient outcomes
at two weeks post-injection, and suggests the potential for improved
therapeutic outcomes at six months. Considering the growing importance
of ofﬁce-based intra-articular procedures to OA treatment, the utility of the
RPD to substantially improve patient safety, comfort and outcomes should
be conﬁrmed in additional studies.
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Purpose: In comparison with WOMAC, the novel self-reported quanti-
tative index Knee Injury and Osteoarthritis Outcome Score (KOOS) has
two new subscales Sport/Recreation (SP/Rec) and Quality of Life (QL).
Recently the short form KOOS-PS was published (Perruccio et al 2008)
which focuses on some components of SP/Rec. There is evidence that
intensive turnover of collage type II takes place in early OA.
Aim: To investigate the associations of the functional limitations ex-
pressed by KOOS with emphasis on the Sp/Rec subscale with (i) ra-
diographic features of early KOA, (ii) degradation of type II collagen
and (iii) low-level inﬂammation in middle-aged women at baseline and
at 3 years.
Methods: A subset of women, including 100 subjects aged 34−54 years
(mean 45) at baseline, from a representative symptomatic cohort of Elva,
South-Estonia, was followed up. BMI> 26 was observed in 66% of the
women.
KOOS: The KOOS questionnaire includes the following subscales: Symp-
toms (S), Pain (P), Activities of daily life (ADL), Sport/recreation (SP/Rec)
and Quality of life (QL). An index value was calculated for every subscale
(0–100; better functional status is expressed by higher index value).
Radiographs: Antero-posterior weight-bearing radiographs of the tibio-
femoral compartment (TF) and axial radiographs of the patello-femoral
(PF) compartment of the knee joint were assessed.
